Capgemini Report: Aging Population to Reshape U.S. P&C Insurance Market by 2050
The Capgemini 2025 P&C Insurance Report outlines how aging populations and climate risks will drive innovation in underwriting and product offerings for U.S. insurers.
The Capgemini 2025 P&C Insurance Report outlines how aging populations and climate risks will drive innovation in underwriting and product offerings for U.S. insurers.
Swiss Re appoints Bernhard Kaufmann as group chief risk officer effective October 2025, along with board re-elections and strategic exit from Asia-Pacific life insurance operations.
Coventry introduces an Enhanced Cash Value program for Universal Life insurance policies, offering faster access to increased cash values without underwriting. This innovation supports advisors and policyholders with enhanced liquidity options.
Reveleer acquires Novillus to enhance its AI-driven value-based care platform, improving payer-provider collaboration, care gap closure, and clinical intelligence for health plans.
Explore key U.S. healthcare reforms to improve support for Alzheimer's caregivers, addressing systemic challenges and policy opportunities for dementia care.
Arizona passes legislation to tighten regulation and oversight of sober living homes following a major Medicaid fraud scheme impacting Native American patients. The law enhances transparency, licensing standards, and reporting protocols for behavioral health providers.
The Supreme Court reviews the constitutionality of the U.S. Preventive Services Task Force's role in ACA preventive care coverage, potentially affecting millions of insured Americans' access to no-cost preventive services.
Proposed Medicaid cuts totaling $880 billion raise concerns over healthcare access for 72 million Americans, with significant impacts on cancer patients and healthcare costs.
Explore how market-driven reforms and reducing regulatory barriers can enhance competition, innovation, and affordability in U.S. health insurance.
Elevance Health reports 15% revenue growth in Q1 2025 driven by Medicare Advantage expansion, premium increases, and CarelonRx portfolio growth, highlighting ongoing healthcare market evolution.